CLASP IID Trial Evaluates Edwards' Pascal Transcatheter Mitral Valve Repair System


December 3, 2018—Atlantic Health System’s Morristown Medical Center announced that the first transcatheter mitral valve repair (TMVR) procedure in the CLASP IID pivotal trial was performed at the center located in Morristown, New Jersey. The CLASP IID trial will evaluate the Pascal TMVR system (Edwards Lifesciences) for patients with degenerative mitral valve regurgitation.

The trial is led by National Principal Investigators Linda Gillam, MD, with Morristown Medical Center; Scott Lim, MD, with the University of Virginia in Charlottesville, Virginia; and Rob Smith, MD, with The Heart Hospital Baylor in Plano, Texas.

In the announcement from Atlantic Health System, Dr. Gillam commented, “We are extremely honored to implant the first device in this trial and to make this therapy available for those we care for.” Dr. Gillam is the Dorothy and Lloyd Huck Chair of the Department of Cardiovascular Medicine at Morristown Medical Center and Medical Director of the Cardiovascular Service Line for Atlantic Health System.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.